期刊
JOURNAL OF MEDICINAL CHEMISTRY
卷 55, 期 3, 页码 1227-1241出版社
AMER CHEMICAL SOC
DOI: 10.1021/jm201368m
关键词
-
资金
- CNRS
- Canceropole Grand Ouest
- Region des Pays de la Loire
- ANR PCV Galcerdeo [ANR-08-PCVI-0024-02]
- L'Association pour la Recherche sur le Cancer (ARC)
- GENCI-CINES/IDRIS [c2011085117]
- CCIPL (Centre de Calcul Intensif des Pays de Loire)
- Agence Nationale de la Recherche (ANR) [ANR-08-PCVI-0024] Funding Source: Agence Nationale de la Recherche (ANR)
We propose here the synthesis and biological evaluation of 0 3,4-dideoxy-GalCer derivatives. The absence of the 3- and 4-hydroxyls on the sphingoid base is combined with the introduction of mono or difluoro substituent at C3 (analogues 8 and 9, respectively) to evaluate their effect on the stability of the ternary CD1d/GalCer/TCR complex which strongly modulate the immune responses. Biological evaluations were performed in vitro on human cells and in vivo in mice and results discussed with support of modeling studies. The fluoro 3,4-dideoxy-GalCer analogues appears as partial agonists compared to KRN7000 for iNKT cell activation, inducing T(H)1 or T(H)2 biases that strongly depend of the mode of antigen presentation, including human vs mouse differences. We evidenced that if a sole fluorine atom is not able to balance the loss of the 3-OH, the presence of a difluorine group at C3 of the sphingosine can significantly restore human iNKT activation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据